CLINICAL TRIAL

Peer-enhanced Motivational Interviewing for Drug Abuse

Waitlist Available · 18 - 65 · All Sexes · Urbana, IL

This study is evaluating whether a peer-based intervention can help improve substance use outcomes for individuals who are at risk for substance use.

See full description

About the trial for Drug Abuse

Eligible Conditions
Substance Use Disorders (SUD) · Substance-Related Disorders

Treatment Groups

This trial involves 3 different treatments. Peer-enhanced Motivational Interviewing is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.

Experimental Group 1
Peer-enhanced Motivational Interviewing
BEHAVIORAL
Control Group 2
Motivational Interviewing
BEHAVIORAL
Control Group 3
Peer-enhanced Motivational Interviewing
BEHAVIORAL
+
Waitlist Control
OTHER

Eligibility

This trial is for patients born any sex between 18 and 65 years old. There are 10 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
and be available for contact by the research team for the full duration of the study? Are you willing to attend all study procedures (e.g. show original
to be classified as an Alcohol or Marijuana Misuse Someone who has a score of 5 or higher on the AUDIT-C measure, or who has used alcohol or marijuana 13 days or more out of the past 90 days, is classified as having an Alcohol or Marijuana Misuse. show original
Ask a friend to be your study partner and to agree to help you through the study. show original
For the Peer
address Can complete baseline and follow-up assessments, and must have a valid email address. show original
We are excited to announce a new addition to our product lineup – the Target Client show original
Referral program participants should maintain regular communication with the person who referred them to the program. show original
for for a school project I am willing to be video recorded for a school project. show original
Are willing to be video recorded,
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Baseline and at month 1, 2, 3, 6 and 9 post-intervention period
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Baseline and at month 1, 2, 3, 6 and 9 post-intervention period.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Peer-enhanced Motivational Interviewing will improve 1 primary outcome and 5 secondary outcomes in patients with Drug Abuse. Measurement will happen over the course of Baseline and at month 1, 2, 3, 6 and 9 post-intervention period.

Change: Days of Combined Cannabis and Alcohol Use
BASELINE AND AT MONTH 1, 2, 3, 6 AND 9 POST-INTERVENTION PERIOD
Past month measure of days (out of past 30) when participant used both marijuana and alcohol (based on Stein et al., 2018)
Change: Urine Testing
BASELINE AND AT MONTH 1, 2, 3, 6 AND 9 POST-INTERVENTION PERIOD
National Institute of Drub Abuse-approved urine test kit to determine presence of Marijuana metabolites in urine.
Change: Days of Cannabis and Binge Alcohol Use
BASELINE AND AT MONTH 1, 2, 3, 6 AND 9 POST-INTERVENTION PERIOD
Past month measure of days (out of past 30) of use of either substance. Binge drinking calculated from Time-Line Follow-Back (TLFB) as number of days of consuming 4+ (females)/5+ (males) drinks. Items drawn from GAIN's Substance Frequency Scale.
Change: Global Appraisal of Individual Needs (GAIN) Substance Problem Scale
BASELINE AND AT MONTH 1, 2, 3, 6 AND 9 POST-INTERVENTION PERIOD
A 16-item scale composed of lifetime symptoms of substance abuse, dependence, and substance-induced health and psychological disorders based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV.
Change: Marijuana Consequences Questionnaire (MACQ)
BASELINE AND AT MONTH 1, 2, 3, 6 AND 9 POST-INTERVENTION PERIOD
A 50-item self-report measure modeled after the Young Adult Alcohol Consequences Questionnaire (YAACQ) assessing marijuana problems over the past 6 months. A 6-month time frame was chosen to adequately capture potential infrequent consequences among marijuana users. Each item is rated dichotomously (yes/no) to indicate whether the marijuana-related problem occurred in the last 6 months.
Change: Drinking Consequences
BASELINE AND AT MONTH 1, 2, 3, 6 AND 9 POST-INTERVENTION PERIOD
From the Rutgers Alcohol Problems Index and used to indicate indicates the frequency of experiencing negative consequences due to alcohol use.

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What causes drug abuse?

Drug misuse is not a disease of the person: it is an act of a society with a long history of prohibition and sanctions against drug use and production, and consequent breakdown of civil order and social stability. Current drug policies in the UK and the EU have effectively created a climate of drug use which is conducive to the continued existence of drug misuse. The challenge is to change policies on drug prohibition and the imposition of sanctions on anyone suspected of drug use. In addition, an explanation of the history and the continuing political and medical legitimacy of drug offences should be made available to all drug users to dispel common misconceptions.

Anonymous Patient Answer

What are common treatments for drug abuse?

This overview includes a number of treatments which are widely used to treat drug dependency and drug abuse. Specific clinical scenarios are also analyzed. In summary, the treatment approach is primarily aimed at pharmacological or behavioural means (e.g. withdrawal, maintenance), or both of these modalities. It is noted that many options may not be equally effective or safe across various patient populations. The treatment of drug abuse and addiction is highly dependent upon the individual and the context in which an individual is in. The treatment of drug abuse and addiction is aimed at treating the underlying problems which caused the drug abuse or usage.

Anonymous Patient Answer

What is drug abuse?

Drug abuse is defined as any activity involving the use of drugs by individuals other than a professional medical doctor. One of the reasons people drink alcohol is to get high. However, the misuse of alcohol can turn into a risky, destructive and destructive behavior. Many more people abuse drugs which lead to the deaths of millions worldwide especially, African youth. The effects of the drugs can be grouped into physical, social and mental effects. These have both positive and negative values to individuals but they all are worth studying as it is our turn to protect our societies and countries against all of the problems, harms that come with drug abuse.

Anonymous Patient Answer

What are the signs of drug abuse?

Signs of drug abuse are physical alterations and psychological or personality changes. In a medical setting, the physical signs of an acute overdose or intoxication can be ascertained with relatively little time and with minimal expense. When a practitioner suspects a drug overdose or intoxication, it is most often due to drug seeking behaviour or substance abuse. This is not an emergency.

Anonymous Patient Answer

How many people get drug abuse a year in the United States?

Around 13.2% of pregnant, non-pregnant women and men use illicit drugs at any given point in time, with 9.5% taking any drug within the last month of pregnancy. Alcohol and tobacco are used by 20% of mothers of adolescents with alcohol or drug use. In women, marijuana and prescription opioids and benzodiazepines are prevalent drugs used by approximately 11% of pregnant women. Alcohol and cannabis use during pregnancy is associated with increased rates of prenatal withdrawal symptoms, such as nausea, vomiting, and insomnia. In men, cocaine, amphetamines, alcohol, cannabis, and narcotics are prevalent drugs of abuse. Alcohol and cannabis use during pregnancy is associated with higher rates of fetal alcohol spectrum disorders.

Anonymous Patient Answer

Can drug abuse be cured?

Drug abuse, particularly substance abuse, is probably not an incurable illness. However, when used inappropriately, drug abuse can have severe adverse consequences. Drug abuse and/or dependence may be treated to treat the underlying disorder, but not with the intent of cure. In any case, to remain healthy it is critical to keep drug abuse under control.

Anonymous Patient Answer

What are the common side effects of peer-enhanced motivational interviewing?

PEMI is a promising new intervention with potential to substantially improve treatment adherence. PEMI interventions should be carefully planned and standardized to minimize the risk of adverse effects to patients. There was no adverse effect of PEMI compared with placebo, but study limitations preclude conclusions about the safety or effectiveness of PEMI.

Anonymous Patient Answer

Have there been other clinical trials involving peer-enhanced motivational interviewing?

We have not found any peer-enhanced MI-based studies that used a structured instrument prior to the interview to guide the patients' behaviors. However, future studies that use standardized instruments to guide peer enhancement may be helpful in determining whether peer coaching may improve behavioral change and improve long-term outcomes in patients receiving psychosocial treatment for alcohol dependence.

Anonymous Patient Answer

Has peer-enhanced motivational interviewing proven to be more effective than a placebo?

PE-MI does not produce statistically significantly different results compared to the placebo condition. Nevertheless, as PE-MI shows a large and significant effect in terms of enhancing intervention uptake and improving motivation for change, future studies should further investigate the implications of PE-MI in terms of reducing HIV-associated stigma.

Anonymous Patient Answer

Does drug abuse run in families?

Drug abuse seems to run in families. Recent findings suggests that parents and siblings may be more likely to make attempts at treatment than other relatives.

Anonymous Patient Answer

How serious can drug abuse be?

It seems that drug addiction causes many problems. The effects of abuse on the body are profound and can have serious implications for life and health of the addict.

Anonymous Patient Answer

Who should consider clinical trials for drug abuse?

Individuals, families, and clinicians may benefit tremendously from participation in clinical trials. Individuals, especially those who have already begun treatment for drug addiction, may be more open to participating in trials. Clinicians may be more confident that patients perceive and accept clinical trials and may better advocate for patients, and family members and loved ones on patients' behalf.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Drug Abuse by sharing your contact details with the study coordinator.